DrugCite

Abilify and Blood Creatine Phosphokinase Increased

This page shows results related to Abilify and Blood Creatine Phosphokinase Increased from the FDA Adverse Event Reporting System (AERS).

Click here to learn about all Abilify adverse events.

Adverse Event
Safe Use Tools
Learn More
Comments

Abilify and Blood Creatine Phosphokinase Increased

Age

40-49 Years
45
>60 Years
42
20-29 Years
23
50-59 Years
23
30-39 Years
19
10-19 Years
17

Gender

Male: 52%
Female: 45%
Gender Unknown: 3%

Outcome

What were the most common outcomes of those reporting Blood Creatine Phosphokinase Increased?

Hospitalization
107
Other
72
Death
20
Life Threatening
15
Disability
6

Reporter

Who most commonly reported Blood Creatine Phosphokinase Increased?

Physician
70
Other
61
Consumer
42
Pharmacist
9

Therapy

Of those reporting Blood Creatine Phosphokinase Increased, why were they taking Abilify?

Schizophrenia
60
Bipolar Disorder
24
Psychotic Disorder
14
Schizoaffective Disorder
14
Drug Use For Unknown Indication
7

Is the adverse drug reaction you’re experiencing actually due to the drug you took?

The Naranjo Scale is a questionnaire for determining the likelihood of whether an adverse drug reaction is actually due to the drug or caused by other factors. Probability is assigned via a score termed definite, probable, possible or doubtful.*

YESNOUNKOWN
Are there previous conclusive reports on this reaction?
Did the adverse event appear after the suspected drug was administered?
Did the adverse reaction improve when the drug was discontinued or a specific antagonist was administered?
Did the adverse reaction reappear when the drug was readministered?
Are there alternative causes (other than the drug) that could on their own have caused the reaction?
Did the reaction reappear when a placebo was given?
Was the drug detected in the blood (or other fluids) in concentrations known to be toxic?
Was the reaction more severe when the dose was increased, or less severe when the dose was decreased?
Did the patient have a similar reaction to the same or similar drugs in any previous exposure?
Was the adverse event confirmed by any objective evidence?
Probability of an Adverse Event
Doubtful
Possible
Probable
Definite

*Naranjo, et al. "A method for estimating the probability of adverse drug reactions." Clin Pharmacol Ther. 1981 Aug;30(2):239-45.

To learn more about all adverse events for Abilify, view the complete Abilify adverse event report.

Scientific Publications on Blood Creatine Phosphokinase Increased

Powered by Google

Comments

Share your experience with Abilify and Blood Creatine Phosphokinase Increased.